Otmezguine Y, Despretz J, Calitchi E, Julien M, Le Bourgeois J P
Département de Cancérologie, Hôpital Henri Mondor, Créteil.
Presse Med. 1989 Oct 28;18(35):1735-8.
Between 1980 and 1987, 25 patients with cancer of the middle or lower rectum were treated with preoperative radiotherapy (35 Gy over 3 weeks) followed, a few weeks later, by "tumorectomy". During surgery, a guiding tube was positioned on the tumoral bed for a localized overdose of curietherapy. The superimpression was 20 Gy for submucosal lesions (7 patients) and 25 Gy for lesions that had invaded the muscle coat (8 cases) or reached the serous coat (10 cases). During a mean follow-up period of 40.5 months, there were 5 recurrences and they all appeared before 18 months had elapsed since the end of treatment. Two of these 5 patients are alive and without metastasis 1 year after a secondary abdominoperineal rectal amputation. The 20 patients who showed no recurrence have normal sphincter function and 19 of them are now alive without evidence of malignancy. In cancer of the middle or lower rectum this conservative approach seems to be suitable for patients who cannot benefit from radical surgery or refuse abdominoperineal rectal amputation.
1980年至1987年间,25例中低位直肠癌患者接受了术前放疗(3周内给予35 Gy),几周后进行“肿瘤切除术”。手术过程中,在肿瘤床放置一根导管,用于局部过量镭疗。对于黏膜下病变(7例患者),追加剂量为20 Gy;对于侵犯肌层(8例)或累及浆膜层(10例)的病变,追加剂量为25 Gy。在平均40.5个月的随访期内,出现了5例复发,且均在治疗结束后18个月内出现。这5例患者中有2例在二次腹会阴联合直肠癌切除术后1年仍存活且无转移。20例未复发的患者括约肌功能正常,其中19例目前存活且无恶性肿瘤迹象。对于中低位直肠癌,这种保守方法似乎适用于无法从根治性手术中获益或拒绝腹会阴联合直肠癌切除术的患者。